FARIBA SERAJ: Open Payments
NPI 1346268919 · REDONDO BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 10 payments from 6 companies in 2025. Trend: 2023 $575 · 2024 $552 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 2 | $134 |
| Janssen Biotech, Inc. | 4 | $83 |
| GENZYME CORPORATION | 1 | $48 |
| Incyte Corporation | 1 | $28 |
| UCB, Inc. | 1 | $25 |
| Galderma Laboratories, L.P. | 1 | $22 |
Products named: DAXI, TREMFYA, DUPIXENT, OPZELURA, Bimzelx, DAXXIFY, AKLIEF.
Industry payments across CA — which companies pay providers there.
